Fixed it up for you Clavis.

regards,

Hg

____________________________________...

Managemenrt

& Directors

OFFICERS

Mr. Michael Cloutier, CEO

Wayne R. Danter MD, FRCPC Director, President and Chief Scientific Officer

Mr. John Drake, Chairman of the Board

Gene Kelly, Chief Financial Officer

Mr. Michael Barr, Director of Business Development and Marketing.

BOARD OF DIRECTORS

Wayne R. Danter MD, FRCPC (3) London, Ontario Director, President and Chief Scientific Officer

Dr. Danter is one of the founders of COTI and the inventor of the CHEMSAS® process. He trained at the University of Western Ontario in Internal Medicine and Clinical Pharmacology and is responsible for the discovery and profiling of the Company’s small molecule libraries and collaboration projects with Pharmaceutical customers. Dr. Danter also plays a significant role in developing the business applications of COTI’s proprietary technology. Prior to full time employment with COTI, Dr. Danter was an Associate Professor of Medicine at the University of Western Ontario.

Michael Cloutier Burlington, Ontario,CEO & Director.

President and CEO of LEXORC Performance Solutions Inc., a consulting services company. Mr. Cloutier has over 26 years of pharmaceutical industry experience having held a number of senior management roles in Canada and internationally. These roles have included; 2007-08 VP Human Resources Global Marketing at AstraZeneca in the UK; 2003-07 President and CEO of AstraZeneca Canada Inc.; 2000-03 President and CEO of Pharmacia Canada following the merger of the Searle division of Monsanto with Pharmacia and Upjohn; 1998-2000 President of Searle Canada. Mr. Cloutier also has international experience as the former Senior Director, Operations for Searle in Latin America/Canada. In addition to his business career, Mr. Cloutier has a strong track record of community involvement and currently serves as the Vice Chair of the Canadian Orthopaedic Foundation and is on the Board of Sheridan College Institute of Technology and Advanced Learning.

John C. Drake LL.B. London, Ontario Chairman of the Board

Mr. Drake is the President and Founding Partner, Drake Goodwin Corporation which position he has held since April 1985. Drake Goodwin Corporation is a London, Canada investment firm with diverse interests in financial services, real estate development and manufacturing. Mr. Drake is also Chairman of the DGM Bank & Trust Inc., a privately owned offshore bank located in the Barbados. Mr. Drake is also a director of Discovery Air Inc., an aviation services company listed on the TSX. Mr. Drake obtained his B.A. and LL.B. degrees from the University of Western Ontario. He is a member of the Law Society of Upper Canada.

Dr. F. Rainer Engelhardt PhD (1) (2) Ottawa, Ontario Director

Dr. Engelhardt is the Chief Executive Officer of Eulytica Biologics Inc.,�a private Ontario-registered life sciences company, focused on infectious disease. Dr. Engelhardt’s career began as a professor at Southeastern Massachusetts University and at the University of Ottawa, specializing in biomedicine. Dr. Engelhardt’s contributions to the advancement of science and technology and its commercial applications have been recognized through numerous awards for his research work, institution building activities and establishment of multi-sector national and international collaboration agreements. He joined the private sector in 1989, as an Executive Vice President with the US-based Marine Spill Response Corporation, a petroleum sector company that he helped create to become globally the largest emergency response company. As founding Chief Executive Officer of the Ottawa Biotechnology Incubation Centre and ongoing as President and as owner of ENOVA Research Applications Inc., he has provided executive management and mentoring for technology-based enterprises during their early phase commercial development. Dr. Engelhardt served as Chairman of Liponex Inc., where he led its transition to becoming publicly traded on the TSX and he was CEO of GangaGen Life Sciences Inc. (Canada) and President and COO of GangaGen Inc. (USA) prior to his current position.

Dr. Kathleen Ferguson MD FRCPC (3) London, Ontario Director

Dr. Ferguson is an Associate Professor of Medicine at the University of Western Ontario Dr. Ferguson is one of the founders of COTI. Dr. Ferguson is a scientist and clinician with an extensive background in clinical research. Dr. Ferguson's understanding of the potential of the CHEMSAS® technology motivated her to participate in the development of a business using this as its core technology. The breadth of her clinical and research experience is an important resource for COTI in developing applications for its technology in the medical and pharmaceutical fields.

Mark Hlady (1) (2) Calgary, Alberta Director

Mr. Hlady is the Chairman of the Board for Kodiak Energy, a small oil and gas company operated out of Calgary, with assets from the NWT in Canada to New Mexico. Mr. Hlady is an accomplished businessman and recognized name in Alberta having served three terms as Member of the Legislative Assembly for Calgary Mountain View from June 1993 until November 2004. During his term in the Alberta Legislature, Mr. Hlady served on many oil and gas and energy related committees including; Chair of the Standing Policy Committee on Energy and Sustainable Development for the Province of Alberta, Canadian Energy Research Institute (CERI), US Energy Council – Executive Committee Foreign Representative, Alberta Representative on the Alaska Highway Pipeline Committee, Director on the Calgary Stampede Board from November 1996 to November 2004. He then served as President and a director of International Petroreal Oil Corporation, an oil production and exploration company until 2008. Mr. Hlady has a Bachelor of P.ED from the University of Calgary.

Bruno Maruzzo (1) (2) Toronto, Ontario Director

President of TechnoVenture Inc., a business and technology consulting company. Mr. Maruzzo has worked with a variety of public and private high technology companies in both the computer and life science sectors, where he held positions in a range of areas including business development, corporate development, investor relations, engineering management and general management. He has also worked in the venture capital field sourcing, assessing and making investments in early-stage, technology-based companies in Canada and the US. He holds a Masters in Biomedical Engineering and a Masters in Business Administration both from the University of Toronto. Mr. Maruzzo is currently a director of Pinetree Capital, a TSX-listed company and Calotto Capital, a TSXV listed company.

Murray Wallace FCA (1) (3) London, Ontario Director

Chairman and CEO of Park Street Capital Corporation, an investment and consulting company. Mr. Wallace is a Fellow of the Institute of Chartered Accountants of Ontario (F.C.A.). He began his business career in Regina in 1972 and held various positions with the Government of Saskatchewan, including that of Deputy Minister of Finance and Deputy Minister to the Premier. Over his 35 year career, Mr. Wallace has held several senior executive roles with prominent organizations including Saskatchewan Government Insurance, National Trust, Royal Trust, Wellington Insurance, Avco Financial Services Canada and Axia NetMedia. Mr. Wallace is currently Chairman and CEO of Park Street Capital Corporation, an investment and consulting company. Mr. Wallace is a Director of Terravest Income Fund, Western Surety Co. and the Canada Pension Plan Investment Board.

Douglas S. Alexander CA London, Ontario A professional Corporate Director

Mr. Alexander is currently Lead Director and Chair of the Audit Committee of Saxon Financial Inc. (Saxon), an investment management firm listed on the TSX. In addition, he is Chair of the Special Committee established for the purposes of considering strategic alternatives for Saxon and reviewing the interest of third parties. He also is currently a Director of Hydrogenics Corporation, a global developer of clean energy solutions focused on commercializing hydrogen and fuel cell products trading on NASDAQ and the TSX. He is a member of their Human Resources and Compensation Committees as well as Chair of their Audit Committee. He served as a Director of Stuart Energy Systems Corporation from 2003 to January 2005 prior to it being acquired by Hydrogenics Corporation. Prior to these directorships, Mr. Alexander served as Chief Financial Officer of various Canadian public companies for 15 years, the most recent being from 1999 to 2004 as executive Vice President and Chief Financial Officer of Trojan Technologies Inc., an international environmental technology company.

Notes:

(1) Member of the Audit Committee

(2) Member of the Compensation Committee

(3)Member of the Governance and Nominating Committee

(4) The Company does not presently have an Executive Committee